CREATE: Art for Children With Cancer
CREATE: Clinical Research Examining the Arts as Targeted Elements in Childhood Cancer Care
3 other identifiers
interventional
72
1 country
1
Brief Summary
This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of complementary health interventions which have been associated with improved quality of life and reduced symptom burden among children with cancer. CrA is an ideal intervention for children with cancer due to the long hours spent in the hospital setting for treatments, the creativity and developmental focus of children, and their potential ability to communicate more easily through art than words. Researchers want to develop and test a CrA intervention to help improve symptoms and the quality of life of children with cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
June 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 30, 2026
March 1, 2026
2.1 years
March 5, 2024
March 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants that complete all interventions and data collection time points
Will be considered feasible if 80% of participants complete 4 intervention sessions and 3 data collection time points. Will be summarized across and within each study arm using means and standard deviations for continuous variables, and frequency counts and percentages for nominal variables.
Up to day 90
Secondary Outcomes (6)
Number of eligible participants that enroll in the study (feasibility threshold of 80%)
Up to to 24 months
Number of participants that complete all interventions and all surveys in the study.
Up to 24 months
Number of intervenor fidelity surveys that obtain at least 95% score.
Up to 24 months
Comparison of scores on the PRO-CTCAE between intervention arms
Up to 24 months
Comparison of scores on the PROMIS between intervention arms
Up to 24 months
- +1 more secondary outcomes
Study Arms (3)
Phase I (focus group)
ACTIVE COMPARATORPatients participate in focus groups to develop CrA intervention on study.
Phase II arm I (CrA)
EXPERIMENTALPatients participate in CrA interventions comprising drawing, painting, and making sculptures with a trained artist for 30 minutes once a week for 4 sessions over 12 weeks.
Phase II arm II (watch videos)
ACTIVE COMPARATORPatients passively watch videos for 30 minutes once a week for 4 sessions over 12 weeks.
Interventions
Participate in art focus group, art-making
Ancillary studies
Eligibility Criteria
You may qualify if:
- Aged 8 to 13 years of age
- Have been diagnosed with cancer of any type in the prior 12 months
- Be English literate (we will amend this criterium when the study surveys are validated in Spanish). Parent/caregiver of child participant may be Spanish speaking
- Physically and cognitively able to participate in creative arts
- Expected to receive enough treatment at local site to participate in all four intervention sessions
You may not qualify if:
- Not English literate
- Otherwise unable to complete study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer L Raybin
OHSU Knight Cancer Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 5, 2024
First Posted
April 2, 2024
Study Start
June 4, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
Will share by publishing in an ICMJE journal and will also submit data and metadata to the Dyad data repository.